Type: Webinar

The Oxford Covid-19 Vaccine Production - A Year in the Fast Lane

Event organised by Ingenieurs et Scientifique de France

Date: 25 January 2021
Time

This event has now ended

Overview

The Clinical Biomanufacturing Facility (CBF) at the University of Oxford (UK) produced the first clinical batches of the ChAdOx1 nCoV-19 vaccine against SARS-coV-2 in April 2020. In collaboration with our industrial partner AstraZeneca we have moved rapidly to get the vaccine into phase III clinical trials across the globe, and interim analysis has shown good safety and efficacy, leading to its licensure in the UK and around the world.

We developed and optimised a route to scaled up manufacture in order to produce millions of doses in the hope that it (in conjunction with other vaccines) will deliver an effective route to end the current pandemic. I will present the efforts that underpinned this highly rapid development of a vaccine against a previously unknown pathogen, the lessons that we have learnt, as well as the results generated from our early phase trials.

For more information please contact:

Shelly-Ann Russell

e: [email protected]

Login or register for a MyICE account

The Oxford Covid-19 Vaccine Production - A Year in the Fast Lane

This event has now ended

Overview

For more information please contact:

More like this

The Oxford Covid-19 Vaccine Production - A Year in the Fast Lane

This event has now ended

Overview

For more information please contact:

Topics:

More like this

5-week course: sustainability

ICE Early Careers Network East Midlands committee meetings

Switch on to time management